MicroRNA profile in very young women with breast cancer

BackgroundBreast cancer is rarely diagnosed in very young women (35years old or younger), and it often presents with distinct clinical-pathological features related to a more aggressive phenotype and worse prognosis when diagnosed at this early age. A pending question is whether breast cancer in very young women arises from the deregulation of different underlying mechanisms, something that will make this disease an entity differentiated from breast cancer diagnosed in older patients.MethodsWe performed a comprehensive study of miRNA expression using miRNA Affymetrix2.0 array on paraffin-embedded tumour tissue of 42 breast cancer patients 35 years old or younger, 17 patients between 45 and 65 years old and 29 older than 65 years. Data were statistically analyzed by t-test and a hierarchical clustering via average linkage method was conducted. Results were validated by qRT-PCR. Putative targeted pathways were obtained using DIANA miRPath online software.ResultsThe results show a differential and unique miRNA expression profile of 121 miRNAs (p-value <0.05), 96 of those with a FDR-value <0.05. Hierarchical clustering grouped the samples according to their age, but not by subtype nor by tumour characteristics. We were able to validate by qRT-PCR differences in the expression of 6 miRNAs: miR-1228*, miR-3196, miR-1275, miR-92b, miR-139 and miR-1207. Moreover, all of the miRNAs maintained the expression trend. The validated miRNAs pointed out pathways related to cell motility, invasion and proliferation.ConclusionsThe study suggests that breast cancer in very young women appears as a distinct molecular signature. To our knowledge, this is the first time that a validated microRNA profile, distinctive to breast cancer in very young women, has been presented. The miRNA signature may be relevant to open an important field of research in order to elucidate the underlying mechanism in this particular disease, which in a more clinical setting, could potentially help to identify therapeutic targets in this particular set of patients.

[1]  N. Rajewsky,et al.  The evolution of gene regulation by transcription factors and microRNAs , 2007, Nature Reviews Genetics.

[2]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[3]  C. Anders,et al.  Debate: The biology of breast cancer in young women is unique. , 2013, The oncologist.

[4]  M. Sherman,et al.  Qualitative age interactions in breast cancer studies: mind the gap. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Vessella,et al.  Novel biomarkers for prostate cancer including noncoding transcripts. , 2009, The American journal of pathology.

[6]  M. Spillman,et al.  Claudins play a role in normal and tumor cell motility , 2013, BMC Cell Biology.

[7]  C. Croce,et al.  Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer , 2013, PloS one.

[8]  R. Gray,et al.  Adjuvant therapy for very young women with breast cancer: need for tailored treatments. , 2001, Journal of the National Cancer Institute. Monographs.

[9]  Xiaowei Xu,et al.  MicroRNA isolation from formalin-fixed, paraffin-embedded tissues. , 2011, Methods in molecular biology.

[10]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[11]  Jianjun Zhang,et al.  Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. , 2012, The international journal of biochemistry & cell biology.

[12]  W. Yong,et al.  Combination Therapy with Gossypol Reveals Synergism against Gemcitabine Resistance in Cancer Cells with High BCL-2 Expression , 2012, PloS one.

[13]  C. Sotiriou,et al.  Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling , 2012, Clinical Cancer Research.

[14]  V. Regitz-Zagrosek,et al.  Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. , 2013, International journal of cardiology.

[15]  C. Sotiriou,et al.  Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer , 2011, PloS one.

[16]  Sung-Liang Yu,et al.  miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells , 2011, Breast Cancer Research.

[17]  D. Glavač,et al.  BBC3 is down-regulated with increased tumor size independently of p53 expression in head and neck cancer. , 2012, Cancer biomarkers : section A of Disease markers.

[18]  T. Veenstra,et al.  The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo , 2010, BMC medicine.

[19]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[20]  C. Larsson,et al.  The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma , 2011, Endocrine-related cancer.

[21]  I. Fentiman,et al.  11. BREAST CANCER IN YOUNG WOMEN , 2002, International journal of clinical practice.

[22]  Ulrich Lehmann,et al.  MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes , 2011, Breast Cancer Research and Treatment.

[23]  R. Young,et al.  Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts. , 2013, Genes & development.

[24]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[25]  R. Wirtz,et al.  Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer , 2012, Breast Cancer Research and Treatment.

[26]  Andrea Sottoriva,et al.  The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.

[27]  S. Majumder,et al.  Emerging role of microRNAs in drug-resistant breast cancer. , 2011, Gene expression.

[28]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[29]  Pietro Panizza,et al.  The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. , 2012, European journal of cancer.

[30]  W. Han,et al.  Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer , 2009, Breast Cancer Research and Treatment.

[31]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[32]  Li Li,et al.  Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer , 2013, PloS one.

[33]  S. Narod.  Breast cancer in young women , 2012, Nature Reviews Clinical Oncology.

[34]  J. Benítez,et al.  Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene , 2012, PloS one.

[35]  G. Tsongalis,et al.  MicroRNAs: novel biomarkers for human cancer. , 2009, Clinical chemistry.

[36]  Michael J Kerin,et al.  Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. , 2010, The oncologist.

[37]  Y. Kondo,et al.  Contribution of MicroRNA-1275 to Claudin11 Protein Suppression via a Polycomb-mediated Silencing Mechanism in Human Glioma Stem-like Cells* , 2012, The Journal of Biological Chemistry.

[38]  M. Cairns,et al.  Schizophrenia is associated with an increase in cortical microRNA biogenesis , 2009, Molecular Psychiatry.

[39]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[40]  Stefania Tommasi,et al.  Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers , 2007, Breast Cancer Research.

[41]  Chris Jay,et al.  miRNA profiling for diagnosis and prognosis of human cancer. , 2007, DNA and cell biology.

[42]  P. Sharp,et al.  The role of miRNAs in regulating gene expression networks. , 2013, Journal of molecular biology.

[43]  S. Hammond,et al.  MicroRNAs as oncogenes. , 2006, Current opinion in genetics & development.

[44]  Jianwen Liu,et al.  MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. , 2012, Biochemical pharmacology.

[45]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[46]  L. Holmberg,et al.  Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control , 2013, BMC Genomics.

[47]  B. Park,et al.  Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women , 2013, PloS one.

[48]  Fatima Al-Shahrour,et al.  Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors. , 2013, Cancer discovery.

[49]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[50]  Charles M Perou,et al.  Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  S. Hammond.  RNAi, microRNAs, and human disease , 2006, Cancer Chemotherapy and Pharmacology.

[52]  B. Yan,et al.  miR-1228 prevents cellular apoptosis through targeting of MOAP1 protein , 2012, Apoptosis.

[53]  Norman F. Boyd,et al.  Relationship of Mammographic Density and Gene Expression: Analysis of Normal Breast Tissue Surrounding Breast Cancer , 2013, Clinical Cancer Research.

[54]  C. Lacombe,et al.  PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype , 2011, Molecular Cancer.

[55]  H. Ditzel,et al.  The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer , 2012, Breast Cancer Research and Treatment.

[56]  J. Marks,et al.  Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors , 2008, PloS one.

[57]  W. Wu,et al.  Derepression of c‐Fos caused by MicroRNA‐139 down‐regulation contributes to the metastasis of human hepatocellular carcinoma , 2013, Cell biochemistry and function.

[58]  T. Martin,et al.  Claudin-11 decreases the invasiveness of bladder cancer cells. , 2011, Oncology reports.

[59]  Sarka Pospisilova,et al.  MicroRNA biogenesis, functionality and cancer relevance. , 2006, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[60]  D. Richardson,et al.  The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets. , 2008, Biochimica et biophysica acta.

[61]  Israel Steinfeld,et al.  miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors , 2011, PloS one.

[62]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[63]  F. Slack,et al.  An elegant miRror: microRNAs in stem cells, developmental timing and cancer , 2009, Chromosoma.

[64]  J. Marks,et al.  Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  P. Gunaratne.  Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells? , 2009, Current stem cell research & therapy.

[66]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[67]  H. Honoré,et al.  Breast cancer in young women. , 1979, British medical journal.

[68]  A. Børresen-Dale,et al.  Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines , 2009, Oncogene.

[69]  Volker Hovestadt,et al.  Molecular and Cellular Pathobiology MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing , 2011 .

[70]  C. Croce,et al.  miRNA profiling of cancer. , 2013, Current opinion in genetics & development.

[71]  Tao Wang,et al.  HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. , 2011, Gastroenterology.

[72]  H. Heneghan,et al.  Circulating miRNA signatures: promising prognostic tools for cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  Chiara Pastrello,et al.  Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. , 2010, Carcinogenesis.

[74]  An-Qin Zhang,et al.  Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels. , 2012, International journal of oncology.

[75]  S. Qin,et al.  Let-7: a regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells. , 2013, Oncology reports.

[76]  Melissa A Troester,et al.  Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients , 2012, Breast Cancer Research.

[77]  Wei Shi,et al.  Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues , 2009, Laboratory Investigation.

[78]  Hong-Yang Wang,et al.  p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. , 2012, Gastroenterology.